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Abstract 
Exercise as a subset of physical activity is a cornerstone in the management of multiple sclerosis 
(MS) based on its pleotropic effects. There is an exponential increase in the quantity of research on 
exercise in MS, yet a number of barriers associated with study content and quality hamper rapid 
progress in the field. To address these barriers and accelerate discovery, a new international 
partnership of MS-related experts in exercise has emerged with the goal of advancing the research 
agenda. As a first step, the expert panel met in May 2018 and identified the most urgent areas for 
moving the field forward, and discussed the framework for such a process. This led to identification 
of five themes, namely “Definitions and terminology”, “Study methodology”, “Reporting and 
outcomes”, “Adherence to exercise”, and “Mechanisms of action”. Based on the identified themes, 
five expert groups have been formed, that will further (a) outline the challenges per theme and (b) 
provide recommendations for moving forward. We aim to involve and collaborate with people with 
MS / MS organizations (e.g. Multiple Sclerosis International Federation (MSIF) and European 
Multiple Sclerosis Platform (EMSP)) in all of these five themes. The generation of this thematic 
framework with multi-expert perspectives can bolster the quality and scope of exercise studies in MS 
that may ultimately improve the daily lives of people with MS.     
  
Introduction 
For many years, exercise was a controversial intervention in multiple sclerosis (MS) as 
it was thought to exacerbate symptoms (1). However, today ample evidence exists that exercise is a 
safe intervention that will benefit most people with MS by improving physical fitness, physical 
function, fatigue, mood, and quality of life(2, 3), along with early evidence suggesting that exercise 
may have disease modifying effects(4-6). The number of exercise studies in MS has increased almost 
exponentially since the millennium (see figure 1), having positive implications for researchers, 
clinicians, and people with MS(7), as exemplified by the development of current MS exercise and 
physical activity guidelines(8-10).  
While the existing knowledge on the effects of exercise in MS should be incorporated 
into our collective understanding of the nature and delivery of exercise interventions, some major 
issues currently limit such common understanding and implementation in clinical practice. The 
following contain examples hereof, that have also been briefly discussed in previous reviews(4, 11). 
First, important definitions and terminologies are not uniform and reporting, such as describing 
recruitment, completion procedures and participant characteristics do not conform to standards. 
Second, there is a lack of consensus on outcomes for monitoring, evaluating and reporting exercise 
interventions (i.e. current metholodical checklists appear insufficient in MS exercise trials). Third, a 
common protocol format of exercise description and performance documentation with respect to 
intensity, duration, and frequency would be helpful when estimating the proposed and applied 
program content. Fourth, consensus is required on the value of biomarkers, ranging from pure fitness 
indicators through inflammatory and neuroprotective markers. Fifth, an in-depth mechanistic 
understanding of the effects of exercise on the central nervous system (CNS) and specifically the 
brain, derived from both animal and human studies, is warranted.  Sixth, the quality of research 
informing the current MS physical activity guidelines are heterogeneous with low evidence and a 
present need to incorporate multiple aspects of physical activity prescription (e.g. effects of physical 
activity versus sedentary behavior along with potential risks thereof) (12). Seventh, the majority of 
published studies have been small numbered (and with that underpowered), evaluating short-term 
exercise interventions(13) that were often biased by recruitment of participants that differed from the 
target population (e.g. already physically active, motivated, and less disabled people with MS) (14, 
15)). Our overall understanding of long-term effects of exercise (particularly whether it is disease 
modifying (16)) and adherence to exercise are currently limited (17).  
Consequently, to optimize the outcome of future MS exercise research, it is time for a 
thorough and critical examination of the most relevant themes limiting progress in MS exercise 
research. These themes were identified at a roundtable meeting by an international expert panel, as 
has previously been done in other neurological disorders, such as stroke(18, 19). Based on the content 
of this first roundtable meeting, the aim of this paper is to (a) summarize the identified themes and 
outline a framework that will guide an updated and optimized MS exercise research agenda, and (b) 
discuss and consider if the research field is capable and ready for large, international multicenter 
efforts that would target the most important research question(s). 
 
Theme identification 
As a first step, a panel of experts from the field were invited to join a roundtable meeting 
held in Amsterdam on May 31st 2018. The panel comprised experts from all areas of the translational 
line, i.e. from basic animal research to real-world clinical implementation. Furthermore, an expert 
from the stroke recovery and rehabilitation task force(18, 19) (Gert Kwakkel) was invited to present 
and share experiences from a similar project undertaken in stroke rehabilitation. The roundtable 
meeting comprised two parts. During the first part, five experts provided brief status presentations 
with each of these followed by panel discussions. Topics included development of a stroke exercise 
research agenda (Gert Kwakkel), current status of MS exercise from a worldwide perspective (Ulrik 
Dalgas), key questions in exercise treatment in MS (Peter Feys), relevant core-set outcomes (Lorna 
Paul), and management of adherence (Susan Coote). During the second part, identification of the 
most relevant research questions were discussed, along with examination of potential study designs 
of future large, international multicenter phase II-IV MS exercise trials.  
The meeting was recorded, and afterwards a report was drafted by the steering 
committee and revised according to comments from the expert panel. Based on the discussions, five 
overall themes were identified in which the expert panel agreed that more in-depth work was needed 
to further optimize future MS exercise research. The identified themes are outlined below. 
  
Figure 1: Literature identified per year since 1950. The search was performed on November 3rd 2019 
using PubMed and the search terms ”exercise” and “multiple sclerosis” (n=2000 studies, top figure), 
along with ”exercise” and “multiple sclerosis” and “randomized controlled trial” (n=276 studies, 
bottom figure). 
 Theme 1: Definitions and Terminology 
Consensus regarding definitions and terms used in MS exercise is lacking. For example, 
several terms are often used interchangeably, such as “exercise” and “rehabilitation” and “physical 
activity”, “inactivity” and “sedentary” and “low fitness”, as well as “neuroprotection” and “neuro-
regeneration” and “neuroplasticity” and “disease-modification”. Furthermore, a thorough description 
of exercise interventions, in terms of frequency, intensity, time and type of activity, as well as 
description of disability-specific adaptations. Expert consensus regarding exercise definitions and 
descriptions ensures a clear understanding of the characteristics of exercise interventions across 
disciplines and accurate knowledge dissemination and translation between researchers, people with 
MS, health professionals and the public(11). One priority area is therefore, to outline and achieve 
consensus on clear definitions of important terms and concepts. This will further underlie the work 
being done within the other identified themes. 
  
Theme 2: Study methodology 
Long-term and large-scale (phase II-IV) exercise intervention trials enrolling people 
with MS are lacking(11). Indeed, the majority of published studies have evaluated short-term 
supervised exercise interventions (≤ 3 months) in small/underpowered samples (≤ 100 
participants)(13). Additional trial-design issues include conceptualization of control groups(20) and 
management of the use of mixed (potentially confounding) disease modifying medications. In 
conducting longer term trials, active comparators seem ethically necessary given the existing 
knowledge on the importance of exercise/physical activity in people with MS. Active comparators 
may likely improve overall adherence (see Theme 4) and internal validity by offering better isolation 
of the “active ingredients” of exercise.  
A critical component for large multi-national trials is access to adequately equipped and 
accessible exercise facilities (i.e. close to individual homes and/or MS clinics), along with 
involvement of qualified health personnel. Such arrangements are not always met, and alternative 
solutions, such as remote technologies, may help overcome these challenges (21). Furthermore, head-
to-head comparisons of different exercise modalities (i.e. resistance, aerobic, balance/stability or 
combinations of these) are required in order to determine the most effective intensities, 
durations/frequencies, and progression models in context of the targeted outcomes. Also, people with 
MS may adapt differently to exercise depending on the type and stage of MS (relapsing-remitting 
versus progressive, early versus late phase) and level of disability (ambulatory or non-ambulatory). 
For example, surprisingly little is known about the effects of exercise in the very early phase of MS.  
Taken together, important issues related to study methodology still remain to be addressed in future 
exercise trials. If ameliorated, the challenges and solutions identified within this theme may form the 
foundation for designing a large aspirational multicenter (phase III) effectiveness trial with higher 
dosing and longer follow up, along with better stratification and more serial assessments over time.  
 
Theme 3: Reporting and Outcomes 
Lack of a standardized approach when performing measurements and reporting 
outcomes in MS exercise trials hampers the ability to advance our understanding of exercise effects, 
limits the advice that can be given to people with MS, and impairs consolidated knowledge from 
research using meta-analyses. Improved reporting may be obtained by adapting and promoting 
existing recommendations such as the TIDieR checklist(22), the Consensus on Exercise Reporting 
Template(23), and other guidelines(24). Acknowledging that the choice of outcomes depends on the 
primary aim of a study, the clinimetric properties of the outcome should always be appropriate to 
discriminate, predict, or evaluate (i.e. responsive). To further advance a more uniform outcome 
approach, application of the Core Outcome Measures in Effectiveness Trials - (COMET) 
(http://www.comet-initiative.org/) and/or the COnsensus-based Standards for the selection of health 
Measurement INstruments - (COSMIN) (https://www.cosmin.nl/) methodology seems relevant. In 
addition, a thorough report of the minimally clinical important change values of trial outcomes is 
needed and confirmation whether the values are consistent across disability levels. Since recent work 
has suggested that typically employed methodological checklists, such as CONSORT and TIDieR, 
may be insufficient in exercise trials, development of specific checklists seem warranted(25). 
Methods to measure and report daily physical activity levels, such as questionnaires and 
accelerometry, is another pressing issue in which no consensus exists. Consensus regarding optimal 
outcome measures to include in exercise trials (e.g. motor, cognitive, quality of life, adverse events) 
is warranted including quantification of activity and participation which arguably have the greatest 
degree of ecological validity. Importantly, people with MS should be involved in the process of 
selecting relevant outcomes (further information in section ‘Moving forward’).  A previously 
published paper on recommended core outcomes in MS exercise studies (26), provides a suitable 
starting point in order to update outcomes, report psychometric properties and add relevant 
biomarkers such as imaging (e.g. MRI) and biological samples (e.g. cytokines, neurotrophins). 
   
Theme 4: Adherence and compliance to exercise 
In exercise studies, “compliance” is often used interchangeably with “adherence”, when 
in fact, they are related but different constructs. Compliance is the extent to which the parameters of 
people with MS's behavior match the prescriber's recommendations(27) whereas adherence refers to 
the extent to which the participant continues with the practice or behavior as agreed(27). The 
“Rehabilitation in MS” (RIMS) organization has endorsed exercise adherence as a major focus 
area(17, 28), however, both compliance (complying with the training parameters/protocol) and 
adherence (longer-term exercise and physical activity commitment and behavioral change) are 
important in order to impact health long-term.  Although psychological strategies that support 
exercise adherence have been examined, the evidence especially from e-health-supported coaching 
strategies in MS, is still in its infancy(29). Related to theme 2 (see above), exercise adherence, 
assessed months or years later, is critical in order to assess the durability/sustainability of exercise 
effects from a trial design perspective. To advance our understanding of adherence, expert people 
with MS will also be engaged while addressing this theme. In addition, the existing adherence 
models(30, 31) will serve as a basis to develop future exercise interventions for people with MS.  
 
Theme 5: Mechanisms of action 
Understanding the underlying mechanisms that explain the beneficial effects of exercise 
in MS is fundamental in order to optimize exercise interventions in general and to tailor optimal 
interventions to single individuals. At present, the available human studies are preliminary, and have 
mainly addressed potential changes in CNS morphology and functioning (i.e. in relation to MRI-
derived changes in volumes and activation of specific brain areas)(5) and blood biomarkers such as 
neurotrophins and inflammatory cytokines. Combining several imaging, biological, and 
neuroperformance markers in exercise trials (e.g. neurophysiology, immunology, neuropsychology, 
biomechanics, vascular changes, blood brain barrier integrity)(32) may help determine whether a 
potential treatment will be beneficial given the person’s clinical profile (personalized approach). 
Experimental studies in animal models of MS have begun to address exercise-induced changes in 
neuronal function(33), although there is still a gap in the alignment and translation to human 
studies(34). Nonetheless, basic biomedical research is essential in order to characterize the potential 
neuroprotective and reparative mechanisms of exercise in MS that cannot be (currently) examined in 
humans(33) and in this way, help inform the design of human/clinical MS studies. 
Altogether, a collective effort is needed to establish a ‘core’ list of the most appropriate biomarkers 
in MS (in alignment with Theme 3), to advance our understanding of any exercise-induced 
translational effects. Also, conceptualization on how to distinguish disease modification from 
symptomatic modification should be considered.  
 
Moving forward  
To move the field forward, five groups, overseen by a project steering committee, will 
be formed to address five identified themes. These five groups/themes will each be chaired by one of 
five different researchers and will have an additional 3-5 members from the panel as well as 1-3 
external members if needed. The steering committee will ensure overarching alignment of the work. 
We aim to establish collaboration with MS patients/organizations (e.g. Multiple Sclerosis 
International Federation (MSIF) and European Multiple Sclerosis Platform (EMSP)) to help guide 
the work within the groups/themes. Financial support will be sought to permit within and between 
group collaboration. Based on this approach, it is expected that a comprehensive, relevant and 
warranted framework can be put forth, forming the basis for improved MS exercise studies and further 
collaborative efforts within the field, ultimately seeking to improve the daily life of people with MS.   
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